Reason for request
Inclusion for an extension of indication
Clinical Benefit
| Substantial |
The actual benefit of VOTRIENT is substantial in th is indication. |
Clinical Added Value
| minor |
VOTRIENT has a minor IAB (level IV) in terms of efficacy compared with the current treatment strategy. |
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
mVATYwTUJkkrpvjZ
